Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 10/10

vs
industry
vs
history
Cash-to-Debt No Debt
GMED's Cash-to-Debt is ranked higher than
87% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: 2.55 vs. GMED: No Debt )
Ranked among companies with meaningful Cash-to-Debt only.
GMED' s Cash-to-Debt Range Over the Past 10 Years
Min: N/A  Med: No Debt Max: No Debt
Current: No Debt
N/A
No Debt
Equity-to-Asset 0.91
GMED's Equity-to-Asset is ranked higher than
94% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. GMED: 0.91 )
Ranked among companies with meaningful Equity-to-Asset only.
GMED' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.83  Med: 0.86 Max: 0.91
Current: 0.91
0.83
0.91
Interest Coverage No Debt
GMED's Interest Coverage is ranked higher than
88% of the 222 Companies
in the Global Medical Devices industry.

( Industry Median: 86.37 vs. GMED: No Debt )
Ranked among companies with meaningful Interest Coverage only.
GMED' s Interest Coverage Range Over the Past 10 Years
Min: No Debt  Med: No Debt Max: No Debt
Current: No Debt
Piotroski F-Score: 5
Altman Z-Score: 21.78
Beneish M-Score: -2.50
WACC vs ROIC
6.79%
20.22%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 26.11
GMED's Operating Margin % is ranked higher than
96% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 2.62 vs. GMED: 26.11 )
Ranked among companies with meaningful Operating Margin % only.
GMED' s Operating Margin % Range Over the Past 10 Years
Min: 23.4  Med: 29.37 Max: 31.61
Current: 26.11
23.4
31.61
Net Margin % 18.09
GMED's Net Margin % is ranked higher than
91% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 1.55 vs. GMED: 18.09 )
Ranked among companies with meaningful Net Margin % only.
GMED' s Net Margin % Range Over the Past 10 Years
Min: 15.79  Med: 18.9 Max: 20.7
Current: 18.09
15.79
20.7
ROE % 13.00
GMED's ROE % is ranked higher than
79% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 1.31 vs. GMED: 13.00 )
Ranked among companies with meaningful ROE % only.
GMED' s ROE % Range Over the Past 10 Years
Min: 13  Med: 17.42 Max: 43.04
Current: 13
13
43.04
ROA % 11.67
GMED's ROA % is ranked higher than
90% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 0.06 vs. GMED: 11.67 )
Ranked among companies with meaningful ROA % only.
GMED' s ROA % Range Over the Past 10 Years
Min: 11.67  Med: 14.62 Max: 36.91
Current: 11.67
11.67
36.91
ROC (Joel Greenblatt) % 57.71
GMED's ROC (Joel Greenblatt) % is ranked higher than
89% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 4.26 vs. GMED: 57.71 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
GMED' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 54.7  Med: 68.29 Max: 139.86
Current: 57.71
54.7
139.86
3-Year Revenue Growth Rate 8.20
GMED's 3-Year Revenue Growth Rate is ranked higher than
64% of the 237 Companies
in the Global Medical Devices industry.

( Industry Median: 4.40 vs. GMED: 8.20 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
GMED' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 8.2  Med: 10.65 Max: 13.5
Current: 8.2
8.2
13.5
3-Year EBITDA Growth Rate 15.90
GMED's 3-Year EBITDA Growth Rate is ranked higher than
62% of the 208 Companies
in the Global Medical Devices industry.

( Industry Median: 5.10 vs. GMED: 15.90 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
GMED' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 4.5  Med: 11.1 Max: 15.9
Current: 15.9
4.5
15.9
3-Year EPS without NRI Growth Rate 13.90
GMED's 3-Year EPS without NRI Growth Rate is ranked higher than
65% of the 203 Companies
in the Global Medical Devices industry.

( Industry Median: 1.40 vs. GMED: 13.90 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
GMED' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 6.8  Med: 13.3 Max: 13.9
Current: 13.9
6.8
13.9
GuruFocus has detected 4 Warning Signs with Globus Medical Inc $GMED.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» GMED's 30-Y Financials

Financials (Next Earnings Date: 2017-05-27 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2016

GMED Guru Trades in Q2 2016

Joel Greenblatt 621,101 sh (+183.63%)
Paul Tudor Jones 117,497 sh (+17.17%)
Steven Cohen 200,000 sh (unchged)
John Hussman Sold Out
Jim Simons 104,700 sh (-69.80%)
» More
Q3 2016

GMED Guru Trades in Q3 2016

Joel Greenblatt 732,178 sh (+17.88%)
Steven Cohen 300,000 sh (unchged)
Jim Simons Sold Out
Paul Tudor Jones 84,093 sh (-28.43%)
» More
Q4 2016

GMED Guru Trades in Q4 2016

Mario Gabelli 19,900 sh (New)
Steven Cohen 414,380 sh (New)
Joel Greenblatt 157,283 sh (-78.52%)
Paul Tudor Jones 11,200 sh (-86.68%)
» More
Q1 2017

GMED Guru Trades in Q1 2017

Steven Cohen 388,700 sh (-6.20%)
Paul Tudor Jones 8,900 sh (-20.54%)
Mario Gabelli 15,500 sh (-22.11%)
Joel Greenblatt 60,521 sh (-61.52%)
» More
» Details

Insider Trades

Latest Guru Trades with GMED

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339112    SIC: 3841
Compare:OTCPK:AMBFF, NAS:WMGI, NAS:LIVN, NYSE:PEN, OTCPK:SHWGY, NAS:IART, NAS:NUVA, NAS:ZLTQ, NYSE:NVRO, OTCPK:EKTAY, OTCPK:FSPKF, OTCPK:NHNKY, OTCPK:GGNDF, NAS:INGN, OTCPK:IOBCF, NAS:CYNO, NAS:MDXG, NAS:MASI, NAS:CNMD, NYSE:ITGR » details
Traded in other countries:GM0N.Germany,
Headquarter Location:USA
Globus Medical Inc is a medical device company focused on developing products that promote healing in patients with musculoskeletal disorders. The Company also develops a robotic surgical navigation device and products to treat patients.

Globus Medical is a medical device company that develops products for patients with musculoskeletal disorders. The firm's products are organized into two categories: innovative fusion and disruptive technologies. The innovative fusion products include fusion products that treat a variety of spinal disorders and can be used in several surgical applications. The disruptive technology products are used for applications such as minimally invasive surgery and new treatment alternatives, including motion preservation and regenerative biologic technologies. Globus Medical generates the vast majority of its revenue in the United States.

Ratios

vs
industry
vs
history
PE Ratio 28.48
GMED's PE Ratio is ranked higher than
51% of the 177 Companies
in the Global Medical Devices industry.

( Industry Median: 27.53 vs. GMED: 28.48 )
Ranked among companies with meaningful PE Ratio only.
GMED' s PE Ratio Range Over the Past 10 Years
Min: 12.96  Med: 23.57 Max: 35.64
Current: 28.48
12.96
35.64
Forward PE Ratio 24.21
GMED's Forward PE Ratio is ranked lower than
57% of the 111 Companies
in the Global Medical Devices industry.

( Industry Median: 21.79 vs. GMED: 24.21 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 28.48
GMED's PE Ratio without NRI is ranked higher than
51% of the 175 Companies
in the Global Medical Devices industry.

( Industry Median: 27.51 vs. GMED: 28.48 )
Ranked among companies with meaningful PE Ratio without NRI only.
GMED' s PE Ratio without NRI Range Over the Past 10 Years
Min: 12.96  Med: 23.57 Max: 35.64
Current: 28.48
12.96
35.64
Price-to-Owner-Earnings 27.90
GMED's Price-to-Owner-Earnings is ranked higher than
62% of the 107 Companies
in the Global Medical Devices industry.

( Industry Median: 32.96 vs. GMED: 27.90 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
GMED' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 17.67  Med: 23.46 Max: 71.82
Current: 27.9
17.67
71.82
PB Ratio 3.42
GMED's PB Ratio is ranked lower than
53% of the 298 Companies
in the Global Medical Devices industry.

( Industry Median: 3.11 vs. GMED: 3.42 )
Ranked among companies with meaningful PB Ratio only.
GMED' s PB Ratio Range Over the Past 10 Years
Min: 2.45  Med: 3.51 Max: 4.94
Current: 3.42
2.45
4.94
PS Ratio 5.15
GMED's PS Ratio is ranked lower than
68% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. GMED: 5.15 )
Ranked among companies with meaningful PS Ratio only.
GMED' s PS Ratio Range Over the Past 10 Years
Min: 2.48  Med: 4.25 Max: 5.62
Current: 5.15
2.48
5.62
Price-to-Free-Cash-Flow 23.68
GMED's Price-to-Free-Cash-Flow is ranked higher than
62% of the 112 Companies
in the Global Medical Devices industry.

( Industry Median: 27.61 vs. GMED: 23.68 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
GMED' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 16.11  Med: 28.01 Max: 75.46
Current: 23.68
16.11
75.46
Price-to-Operating-Cash-Flow 17.64
GMED's Price-to-Operating-Cash-Flow is ranked higher than
56% of the 140 Companies
in the Global Medical Devices industry.

( Industry Median: 20.26 vs. GMED: 17.64 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
GMED' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 12.28  Med: 19.72 Max: 32.2
Current: 17.64
12.28
32.2
EV-to-EBIT 17.50
GMED's EV-to-EBIT is ranked higher than
68% of the 275 Companies
in the Global Medical Devices industry.

( Industry Median: 24.54 vs. GMED: 17.50 )
Ranked among companies with meaningful EV-to-EBIT only.
GMED' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.7  Med: 13.9 Max: 21.3
Current: 17.5
6.7
21.3
EV-to-EBITDA 13.53
GMED's EV-to-EBITDA is ranked higher than
68% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 19.31 vs. GMED: 13.53 )
Ranked among companies with meaningful EV-to-EBITDA only.
GMED' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.7  Med: 11.8 Max: 17.9
Current: 13.53
5.7
17.9
PEG Ratio 2.55
GMED's PEG Ratio is ranked higher than
52% of the 83 Companies
in the Global Medical Devices industry.

( Industry Median: 2.52 vs. GMED: 2.55 )
Ranked among companies with meaningful PEG Ratio only.
GMED' s PEG Ratio Range Over the Past 10 Years
Min: 1.39  Med: 2.09 Max: 2.55
Current: 2.55
1.39
2.55
Current Ratio 7.18
GMED's Current Ratio is ranked higher than
88% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 2.38 vs. GMED: 7.18 )
Ranked among companies with meaningful Current Ratio only.
GMED' s Current Ratio Range Over the Past 10 Years
Min: 4.88  Med: 6.87 Max: 10.12
Current: 7.18
4.88
10.12
Quick Ratio 5.68
GMED's Quick Ratio is ranked higher than
86% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 1.79 vs. GMED: 5.68 )
Ranked among companies with meaningful Quick Ratio only.
GMED' s Quick Ratio Range Over the Past 10 Years
Min: 3.82  Med: 5.56 Max: 8.29
Current: 5.68
3.82
8.29
Days Inventory 289.51
GMED's Days Inventory is ranked lower than
84% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 130.04 vs. GMED: 289.51 )
Ranked among companies with meaningful Days Inventory only.
GMED' s Days Inventory Range Over the Past 10 Years
Min: 125.66  Med: 265.97 Max: 295.28
Current: 289.51
125.66
295.28
Days Sales Outstanding 59.25
GMED's Days Sales Outstanding is ranked higher than
63% of the 272 Companies
in the Global Medical Devices industry.

( Industry Median: 68.94 vs. GMED: 59.25 )
Ranked among companies with meaningful Days Sales Outstanding only.
GMED' s Days Sales Outstanding Range Over the Past 10 Years
Min: 50.59  Med: 52.25 Max: 59.53
Current: 59.25
50.59
59.53
Days Payable 44.70
GMED's Days Payable is ranked lower than
59% of the 259 Companies
in the Global Medical Devices industry.

( Industry Median: 59.71 vs. GMED: 44.70 )
Ranked among companies with meaningful Days Payable only.
GMED' s Days Payable Range Over the Past 10 Years
Min: 28.24  Med: 45.7 Max: 52.41
Current: 44.7
28.24
52.41

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -0.90
GMED's 3-Year Average Share Buyback Ratio is ranked higher than
70% of the 218 Companies
in the Global Medical Devices industry.

( Industry Median: -3.90 vs. GMED: -0.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
GMED' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -1.6  Med: -1.2 Max: -0.8
Current: -0.9
-1.6
-0.8

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 12.69
GMED's Price-to-Net-Cash is ranked higher than
56% of the 103 Companies
in the Global Medical Devices industry.

( Industry Median: 17.13 vs. GMED: 12.69 )
Ranked among companies with meaningful Price-to-Net-Cash only.
GMED' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 0  Med: 13 Max: 31.3
Current: 12.69
0
31.3
Price-to-Net-Current-Asset-Value 6.62
GMED's Price-to-Net-Current-Asset-Value is ranked higher than
50% of the 206 Companies
in the Global Medical Devices industry.

( Industry Median: 6.88 vs. GMED: 6.62 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
GMED' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 0  Med: 5.76 Max: 7.36
Current: 6.62
0
7.36
Price-to-Tangible-Book 4.24
GMED's Price-to-Tangible-Book is ranked lower than
51% of the 263 Companies
in the Global Medical Devices industry.

( Industry Median: 4.11 vs. GMED: 4.24 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
GMED' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.65  Med: 3.89 Max: 5.51
Current: 4.24
2.65
5.51
Price-to-Intrinsic-Value-Projected-FCF 1.78
GMED's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
63% of the 129 Companies
in the Global Medical Devices industry.

( Industry Median: 2.23 vs. GMED: 1.78 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
GMED' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0  Med: 1.6 Max: 1.8
Current: 1.78
0
1.8
Price-to-Median-PS-Value 1.21
GMED's Price-to-Median-PS-Value is ranked lower than
61% of the 242 Companies
in the Global Medical Devices industry.

( Industry Median: 1.03 vs. GMED: 1.21 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
GMED' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0  Med: 0.99 Max: 1.33
Current: 1.21
0
1.33
Price-to-Peter-Lynch-Fair-Value 2.47
GMED's Price-to-Peter-Lynch-Fair-Value is ranked lower than
65% of the 57 Companies
in the Global Medical Devices industry.

( Industry Median: 1.61 vs. GMED: 2.47 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
GMED' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0  Med: 1.76 Max: 2.5
Current: 2.47
0
2.5
Price-to-Graham-Number 2.31
GMED's Price-to-Graham-Number is ranked lower than
52% of the 138 Companies
in the Global Medical Devices industry.

( Industry Median: 2.19 vs. GMED: 2.31 )
Ranked among companies with meaningful Price-to-Graham-Number only.
GMED' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0  Med: 2.05 Max: 2.96
Current: 2.31
0
2.96
Earnings Yield (Greenblatt) % 5.72
GMED's Earnings Yield (Greenblatt) % is ranked higher than
80% of the 432 Companies
in the Global Medical Devices industry.

( Industry Median: 2.17 vs. GMED: 5.72 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
GMED' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 4.7  Med: 7.2 Max: 15
Current: 5.72
4.7
15
Forward Rate of Return (Yacktman) % 14.25
GMED's Forward Rate of Return (Yacktman) % is ranked higher than
64% of the 125 Companies
in the Global Medical Devices industry.

( Industry Median: 8.85 vs. GMED: 14.25 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
GMED' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 14  Med: 14.4 Max: 16.1
Current: 14.25
14
16.1

More Statistics

Revenue (TTM) (Mil) $580.5
EPS (TTM) $ 1.09
Beta0.76
Short Percentage of Float15.00%
52-Week Range $19.25 - 33.06
Shares Outstanding (Mil)96.09

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 626 690 766
EPS ($) 1.27 1.43 1.62
EPS without NRI ($) 1.27 1.43 1.62
EPS Growth Rate
(Future 3Y To 5Y Estimate)
10.00%
Dividends per Share ($)
» More Articles for GMED

Headlines

Articles On GuruFocus.com
Globus Medical Schedules First Quarter 2017 Earnings Release and Conference Call Apr 17 2017 
Globus Medical to Present at Leerink Partners 6th Annual Global Healthcare Conference 2017 Feb 09 2017 
Globus Medical Schedules Fourth Quarter and Full Year 2016 Earnings Release and Conference Call Feb 07 2017 
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Globus Medical, Inc. of Pendency o Oct 08 2015 
Weekly CEO Sells Highlight: Globus Medical Inc, Diplomat Pharmacy Inc, Zendesk Inc, and Amicus Thera Mar 28 2015 

More From Other Websites
Edited Transcript of GMED earnings conference call or presentation 3-May-17 9:30pm GMT May 06 2017
Globus Medical beats 1Q profit forecasts May 03 2017
Globus Medical Reports First Quarter 2017 Results May 03 2017
ETFs with exposure to Globus Medical, Inc. : April 28, 2017 Apr 28 2017
Globus Medical Schedules First Quarter 2017 Earnings Release and Conference Call Apr 17 2017
Globus Medical Stands On The Brink Of Inflection; Leerink Upgrades Apr 12 2017
Globus Medical, Inc. :GMED-US: Earnings Analysis: 2016 By the Numbers : March 2, 2017 Mar 02 2017
Edited Transcript of GMED earnings conference call or presentation 27-Feb-17 10:30pm GMT Feb 28 2017
Globus Medical misses 4Q profit forecasts Feb 27 2017
Globus Medical Reports Full Year and Fourth Quarter 2016 Results Feb 27 2017
ETFs with exposure to Globus Medical, Inc. : January 3, 2017 Jan 03 2017
ETFs with exposure to Globus Medical, Inc. : December 6, 2016 Dec 06 2016
Globus Medical, Inc. breached its 50 day moving average in a Bullish Manner : GMED-US : December 6,... Dec 06 2016
Hedge Funds Are Ditching Globus Medical Inc (GMED): Have They Uncovered Something You Haven’t? Dec 04 2016
Globus Medical and UMB Financial Set to Join S&P MidCap 400; HomeStreet to Join S&P SmallCap 600 Dec 02 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)